Champaign, IL, United States of America

Lin-Feng Chen

This inventor holds 1 USPTO granted patent. Top assignee: University of Illinois. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin-Feng Chen. Retrieved from https://idiyas.com/inventor/lin-feng-chen-v5qu26c2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lin-Feng Chen: Innovator in Antimicrobial Peptides

Introduction

Lin-Feng Chen is a prominent inventor based in Champaign, IL (US). He has made significant contributions to the field of antimicrobial research. His innovative work focuses on developing new methods to combat bacterial infections, particularly in the stomach.

Latest Patents

Lin-Feng Chen holds a patent for "Conformation switchable antimicrobial peptides and methods of using the same." This patent describes a class of pH-sensitive, helix/random conformation switchable antimicrobial polypeptide (HRS-AMP) compositions. These compositions are designed to selectively kill bacteria under acidic conditions in the stomach, offering a solution with diminished bacterial resistance compared to currently used antibiotics. The patent also outlines methods for treating bacterial infections in the stomach.

Career Highlights

Lin-Feng Chen is affiliated with the University of Illinois, where he conducts his research. His work has garnered attention for its potential to revolutionize the treatment of bacterial infections. With 1 patent to his name, he continues to push the boundaries of antimicrobial research.

Collaborations

Lin-Feng Chen has collaborated with notable colleagues, including Jianjun Cheng and Menghua Xiong. Their combined expertise enhances the research efforts in the field of antimicrobial peptides.

Conclusion

Lin-Feng Chen is a key figure in the development of innovative antimicrobial solutions. His work promises to improve treatment options for bacterial infections, showcasing the importance of research in this critical area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…